Xeris Biopharma Holdings Stock (NASDAQ: XERS) stock price, news, charts, stock research, profile.
Open | $1.800 |
Close | - |
Volume / Avg. | 112.356K / 1.952M |
Day Range | 1.750 - 1.800 |
52 Wk Range | 1.460 - 3.260 |
Market Cap | $244.389M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 26 |
Short Interest | 6.53% |
Days to Cover | 5.8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Xeris Biopharma Holdings (NASDAQ: XERS) through any online brokerage.
Other companies in Xeris Biopharma Holdings’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Terns Pharma (NASDAQ:TERN), Rani Therapeutics Hldgs (NASDAQ:RANI) and Aquestive Therapeutics (NASDAQ:AQST).
The latest price target for Xeris Biopharma Holdings (NASDAQ: XERS) was reported by Oppenheimer on Thursday, March 28, 2024. The analyst firm set a price target for 5.00 expecting XERS to rise to within 12 months (a possible 177.78% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Xeris Biopharma Holdings (NASDAQ: XERS) is $1.8 last updated Today at April 18, 2024 at 9:29 AM EDT.
There are no upcoming dividends for Xeris Biopharma Holdings.
Xeris Biopharma Holdings’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Xeris Biopharma Holdings.
Xeris Biopharma Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.